Living donor lung transplantation

World Journal of Surgery
R G Cohen, V A Starnes

Abstract

Since 1993 a total of 101 living-donor bilateral lung transplants have been performed with acceptable results when compared with those utilizing cadaveric lung grafts. Though most recipients were patients with cystic fibrosis who were rapidly deteriorating, the indications for live-donor lung transplantation have been expanded to include some cystic fibrosis patients in a more elective setting, as well as select patients with other end-stage pulmonary diseases. One-year Kaplan-Meler recipient survival is 72%. Seventy-six percent of deaths occur within the first 2 months after transplantation. The most common cause of death is infection, which accounts for 62% of the 1-year mortality rate. The incidence of rejection is 0.8 episodes per patient. Thirty percent of rejection episodes are unilateral, and most tend to be mild. Altogether, 203 patients have undergone donor lobectomy, with a mean age of 37 +/- 12 years (range 18-56 years). Operations included left lower lobectomy (102 patents), right lower lobectomy (97 patients), and right middle and lower lobectomy (4 patients). There has been no donor mortality. Postoperative Rand 36 Question Quality of Life scores, rating physical function, social functioning, and role limitation d...Continue Reading

Citations

Jun 29, 2005·The Journal of Heart and Lung Transplantation : the Official Publication of the International Society for Heart Transplantation·Katsumasa MiyajiTohru Ohe
Sep 7, 2005·The Journal of Heart and Lung Transplantation : the Official Publication of the International Society for Heart Transplantation·Filip R RegaDirk E M Van Raemdonck
Jan 31, 2004·The Journal of Thoracic and Cardiovascular Surgery·Vaughn A StarnesMark L Barr
Feb 5, 2004·The Annals of Thoracic Surgery·Filip R RegaDirk E M Van Raemdonck
Aug 21, 2003·The Journal of Thoracic and Cardiovascular Surgery·Hiroshi DateNobuyoshi Shimizu
Dec 11, 2003·The Journal of Thoracic and Cardiovascular Surgery·Stefan FischerMartin Strüber
Feb 28, 2003·Lancet·Felix Ratjen, Gerd Döring
May 23, 2002·Journal of the American College of Surgeons·Jean C Emond
Apr 5, 2008·European Journal of Pediatrics·Marijke ProesmansKris De Boeck
Feb 24, 2011·Medicina intensiva·E MiñambresM A Ballesteros
Oct 9, 2007·The Journal of Heart and Lung Transplantation : the Official Publication of the International Society for Heart Transplantation·Ilhan InciWalter Weder
Jan 30, 2007·The Journal of Thoracic and Cardiovascular Surgery·Marc De PerrotShaf Keshavjee
Mar 20, 2004·Pediatric Pulmonology. Supplement·Marlyn S Woo
Jan 18, 2005·The Journal of Heart and Lung Transplantation : the Official Publication of the International Society for Heart Transplantation·Filip R RegaDirk E M Van Raemdonck
Oct 13, 2004·The Journal of Heart and Lung Transplantation : the Official Publication of the International Society for Heart Transplantation·Marc de PerrotShaf Keshavjee
Sep 15, 2004·Journal of Cardiothoracic and Vascular Anesthesia·Cornelis VeekenKatherine P Grichnik
Sep 1, 2004·Journal of the American Society of Echocardiography : Official Publication of the American Society of Echocardiography·Katsumasa MiyajiTohru Ohe
Jan 3, 2006·Transplantation Proceedings·M L BarrV A Starnes
Dec 21, 2005·The Journal of Heart and Lung Transplantation : the Official Publication of the International Society for Heart Transplantation·Leah M BackhusRoss M Bremner
Sep 19, 2003·Chest Surgery Clinics of North America·Michael E BowdishVaughn A Starnes
Nov 27, 2004·Clinics in Chest Medicine·Brandon S Lu, Sangeeta M Bhorade
Jun 27, 2006·Journal of Cystic Fibrosis : Official Journal of the European Cystic Fibrosis Society·Khin M GyiMagdi Y Yacoub
Aug 13, 2008·Jornal brasileiro de pneumologia : publicaça̋o oficial da Sociedade Brasileira de Pneumologia e Tisilogia·Paulo Manuel Pêgo FernandesFabio Biscegli Jatene
Sep 19, 2003·Chest Surgery Clinics of North America·Clemens AignerWalter Klepetko

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.